US 12061206
Diagnosis and treatment of autoimmune diseases
granted A61PA61P1/00A61P1/04
Quick answer
US patent 12061206 (Diagnosis and treatment of autoimmune diseases) held by Takeda Pharmaceutical Company Limited expires Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Aug 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P19/02, A61P29/00